ADMA Biologics Reports 2012 Year End Financial and Operational Results

Mar 6, 2013

ADMA Biologics Executes Long-Term Manufacturing, Supply and License Agreements with Biotest

Jan 10, 2013

ADMA Biologics Secures Up To $6 Million Term Loan Commitment To Advance Phase III Study

Jan 7, 2013

ADMA Biologics Reports 2012 Third Quarter Results

Nov 13, 2012

ADMA Biologics to Present at the Rodman & Renshaw Annual Global Investment Conference

Sep 6, 2012

ADMA Biologics Reports 2012 Second Quarter Results

Aug 14, 2012

ADMA Biologics Appoints Plasma Industry Leader Lawrence Guiheen to Board of Directors

Jul 24, 2012

ADMA Biologics Appoints James Mond, M.D., Ph.D. as Chief Medical and Scientific Officer

Jul 23, 2012

ADMA Biologics Appoints Brian Lenz as Chief Financial Officer

May 3, 2012

ADMA Biologics Completes Merger and Closes $17.5 Million Private Placement

Feb 14, 2012